Mary Cushman/X
Oct 12, 2025, 11:28
Is it time for GLP1 receptor agonists in VTE care?
Mary Cushman, Hematologist, University Distinguished Professor and Vice Chair for Emerging Researchers at UVM Department of Medicine, posted on X:
”Is it time for GLP1 receptor agonists in VTE care?
– In people with BMI >30, GLP-1 RA associated w/ 27% lower risk of venous thrombosis compared to use of other obesity reducing meds.
– Data from EHRs of 140 institutions.
– Target trial design.”
Stay updated with Hemostasis Today.
-
Sep 7, 2026, 09:31Felix Scholkmann: Serotonin and the Formation of Microvascular Fibrin
-
Sep 7, 2026, 09:22Aryan Mishra: β-Thalassemia Analyzer: HPLC for Hemoglobinopathy Screening
-
Sep 7, 2026, 09:04Daniel Pereira Monteiro: Haemopaedia Case of the Week – Hemoglobinopathy Diagnosis and Confirmatory Testing
-
Sep 7, 2026, 08:51Judith de Vos: The Immune Composition of Thrombi in Ischemic Stroke
-
Sep 7, 2026, 08:50Maria Cherska: Lipid Metabolism and Immune Remodeling in Metastatic Colorectal Cancer
-
Sep 7, 2026, 08:28Deanna Joseph: Exploring Factor XIII Deficiency Through Summer Research
-
Sep 7, 2026, 08:17Nasim Hosseini: Women’s Blood Donation and the Social Determinants of Health
-
Sep 7, 2026, 08:12David McIntosh: The Global Plasma Supply Debate
-
Sep 7, 2026, 08:03Julio Avella: Advancing IDA Care Through Scientific Education and Collaboration